Introduction: The aim of this study was to identify, quantify and evaluate the use of robotic materials and operating theatre times in Telelap ALF-X robotic hysterectomy. Materials and methods: Cost analysis was performed on 81 patients who underwent a Telelap ALF-X robotic hysterectomy. Data were collected during a phase II study trial conducted at the University Hospital A. Gemelli, Catholic University, Rome. According to micro-costing technique, surgical team costs, materials and operating theatre usage were recorded during each surgical intervention. Cost data were provided by the hospital's accounting office. Probabilistic sensitivity analysis was carried out in order to test the robustness of the results by assuming an Inv-norm random variable. Results: The base case analysis showed a cost/patient of €3391.82. The new robotic device requires a low consumption of robotic materials. Sensitivity analysis showed that the most sensitive cost driver was use of the operating theatre. Conclusion: This study shows that Telelap ALF-X robotic hysterectomy is feasible and safe and could offer specific advantages in terms of cost. Copyright © 2016 John Wiley & Sons, Ltd.

Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy / Rossitto, C.; Gueli Alletti, S.; Romano, F.; Fiore, A.; Coretti, S.; Oradei, M.; Ruggeri, M.; Cicchetti, A.; Marchetti, M.; Fanfani, F.; Scambia, G.. - In: THE INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY. - ISSN 1478-5951. - 12:4(2016), pp. 613-619. [10.1002/rcs.1724]

Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy

Coretti S.;
2016

Abstract

Introduction: The aim of this study was to identify, quantify and evaluate the use of robotic materials and operating theatre times in Telelap ALF-X robotic hysterectomy. Materials and methods: Cost analysis was performed on 81 patients who underwent a Telelap ALF-X robotic hysterectomy. Data were collected during a phase II study trial conducted at the University Hospital A. Gemelli, Catholic University, Rome. According to micro-costing technique, surgical team costs, materials and operating theatre usage were recorded during each surgical intervention. Cost data were provided by the hospital's accounting office. Probabilistic sensitivity analysis was carried out in order to test the robustness of the results by assuming an Inv-norm random variable. Results: The base case analysis showed a cost/patient of €3391.82. The new robotic device requires a low consumption of robotic materials. Sensitivity analysis showed that the most sensitive cost driver was use of the operating theatre. Conclusion: This study shows that Telelap ALF-X robotic hysterectomy is feasible and safe and could offer specific advantages in terms of cost. Copyright © 2016 John Wiley & Sons, Ltd.
2016
cost analysis; economics; gynaecological surgery; healthcare cost; robotic surgery; Telelap Alf-X; Algorithms; Costs and Cost Analysis; Endometrial Neoplasms; Female; Humans; Hysterectomy; Operating Rooms; Pain Measurement; Probability; Robotic Surgical Procedures; Treatment Outcome; Operative Time
01 Pubblicazione su rivista::01a Articolo in rivista
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy / Rossitto, C.; Gueli Alletti, S.; Romano, F.; Fiore, A.; Coretti, S.; Oradei, M.; Ruggeri, M.; Cicchetti, A.; Marchetti, M.; Fanfani, F.; Scambia, G.. - In: THE INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY. - ISSN 1478-5951. - 12:4(2016), pp. 613-619. [10.1002/rcs.1724]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1639523
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 18
social impact